• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测鼻咽癌患者等待时间延长和放疗疗程更长的因素:一项多水平分析

Factors predict prolonged wait time and longer duration of radiotherapy in patients with nasopharyngeal carcinoma: a multilevel analysis.

作者信息

Chen Po-Chun, Yang Ching-Chieh, Wu Cheng-Jung, Liu Wen-Shan, Huang Wei-Lun, Lee Ching-Chih

机构信息

Department of Radiation Oncology, Pingtung Christian Hospital, Pingtung, Taiwan.

Department of Radiation Oncology, Chi-Mei Medical Center, Tainan, Taiwan.

出版信息

PLoS One. 2014 Oct 14;9(10):e109930. doi: 10.1371/journal.pone.0109930. eCollection 2014.

DOI:10.1371/journal.pone.0109930
PMID:25314009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4196956/
Abstract

PURPOSE

Radiotherapy with or without chemotherapy is the primary treatment for patients with nasopharyngeal carcinoma (NPC). It wastes time from diagnosis to treatment. Treatment time of radiotherapy generally takes at least seven weeks. The current study aimed to evaluate factors associated with prolonged wait time and longer duration of radiotherapy in NPC patients.

METHODS AND MATERIALS

From Taiwan's National Health Insurance research database, we identified 3,605 NPC patients treated with radiotherapy between 2008 and 2011. Wait time was calculated from the date of diagnosis to the start of radiotherapy. The impact of each variable on wait time and duration of radiotherapy was examined by multilevel analysis using a random-intercept model.

RESULTS

The mean wait time and duration of radiotherapy were 1.78±3.33 and 9.72±7.27 weeks, respectively. Multilevel analysis revealed prolonged wait time in patients aged 45-65 years, those receiving radiotherapy alone, those with more comorbidities, those with low SES, and those living in eastern Taiwan. A prolonged duration of radiotherapy was associated with receipt of concurrent chemoradiotherapy, more comorbidities, and moderate SES.

CONCLUSIONS

Understanding the factors associated with longer wait times and duration of radiotherapy in patients with NPC may help healthcare providers better assist both these patients and potentially those with other head-and-neck cancers.

摘要

目的

放疗联合或不联合化疗是鼻咽癌(NPC)患者的主要治疗方法。从诊断到治疗会浪费时间。放疗的治疗时间通常至少需要七周。本研究旨在评估与NPC患者等待时间延长和放疗持续时间延长相关的因素。

方法和材料

从台湾国民健康保险研究数据库中,我们确定了2008年至2011年间接受放疗的3605例NPC患者。等待时间从诊断日期计算至放疗开始日期。使用随机截距模型通过多水平分析检查每个变量对等待时间和放疗持续时间的影响。

结果

放疗的平均等待时间和持续时间分别为1.78±3.33周和9.72±7.27周。多水平分析显示,年龄在45 - 65岁的患者、仅接受放疗的患者、合并症较多的患者、社会经济地位较低的患者以及居住在台湾东部的患者等待时间延长。放疗持续时间延长与接受同步放化疗、合并症较多以及中等社会经济地位相关。

结论

了解与NPC患者等待时间延长和放疗持续时间延长相关的因素,可能有助于医疗服务提供者更好地帮助这些患者以及潜在的其他头颈癌患者。

相似文献

1
Factors predict prolonged wait time and longer duration of radiotherapy in patients with nasopharyngeal carcinoma: a multilevel analysis.预测鼻咽癌患者等待时间延长和放疗疗程更长的因素:一项多水平分析
PLoS One. 2014 Oct 14;9(10):e109930. doi: 10.1371/journal.pone.0109930. eCollection 2014.
2
The impact of time factors on overall survival in patients with nasopharyngeal carcinoma: a population-based study.时间因素对鼻咽癌患者总生存的影响:一项基于人群的研究。
Radiat Oncol. 2016 Apr 27;11:62. doi: 10.1186/s13014-016-0638-2.
3
Comparison the clinical outcomes with altered versus conventional fractionated radiotherapy plus concurrent chemotherapy for advanced nasopharyngeal carcinoma.比较改变分割与常规分割放疗联合同期化疗治疗晚期鼻咽癌的临床结果。
Head Neck. 2018 Jun;40(6):1156-1163. doi: 10.1002/hed.25084. Epub 2018 Feb 1.
4
Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.鼻咽癌患者感音神经性听力损失的长期预后:单纯放疗与放化疗的比较
Cell Biochem Biophys. 2014 Jul;69(3):433-7. doi: 10.1007/s12013-014-9814-x.
5
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.IVA 和 IVB 期鼻咽癌患者诱导化疗后同期放化疗与单纯同期放化疗的随机 III 期试验的最终结果 - 台湾癌症合作组(TCOG)1303 研究。
Ann Oncol. 2018 Sep 1;29(9):1972-1979. doi: 10.1093/annonc/mdy249.
6
Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-up.流行地区晚期鼻咽癌患者同步放化疗与新辅助化疗后放疗的比较:128例连续病例5年随访经验
BMC Cancer. 2014 Oct 28;14:787. doi: 10.1186/1471-2407-14-787.
7
Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.鼻咽癌:来自印度一家三级医疗中心的根治性适形放疗经验及治疗结果
Indian J Cancer. 2017 Jul-Sep;54(3):502-507. doi: 10.4103/ijc.IJC_287_17.
8
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma.NPC-0501试验的初步结果,该试验评估了局部晚期鼻咽癌患者从同步辅助放化疗改为诱导-同步放化疗、从氟尿嘧啶改为卡培他滨以及从常规放疗分割改为加速放疗分割后的治疗获益情况。
Cancer. 2015 Apr 15;121(8):1328-38. doi: 10.1002/cncr.29208. Epub 2014 Dec 19.
9
The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis.同期放化疗治疗局部晚期 T 期鼻咽癌中断放疗对局部控制的不良影响:一项观察性、前瞻性分析。
BMC Cancer. 2018 Jul 16;18(1):740. doi: 10.1186/s12885-018-4495-2.
10
Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.调强放疗时代,Ⅱ期和低危Ⅲ~Ⅳ期鼻咽癌序贯放化疗的作用:倾向评分匹配分析。
Oral Oncol. 2018 Mar;78:37-45. doi: 10.1016/j.oraloncology.2018.01.008. Epub 2018 Feb 20.

引用本文的文献

1
Efficiency of high cumulative cisplatin dose in high- and low-risk patients with locoregionally advanced nasopharyngeal carcinoma.局部晚期鼻咽癌中高危患者大剂量顺铂化疗的疗效。
Cancer Med. 2022 Feb;11(3):715-727. doi: 10.1002/cam4.4477. Epub 2021 Dec 3.
2
The Effect of Prolonged Duration of Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma.调强放射治疗持续时间对鼻咽癌的影响
Front Oncol. 2021 Sep 14;11:648637. doi: 10.3389/fonc.2021.648637. eCollection 2021.
3
The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC).吸烟与合并症对头颈部鳞状细胞癌(HNSCC)原发或辅助放(化)疗中剂量达成的影响
Front Oncol. 2020 Mar 24;10:398. doi: 10.3389/fonc.2020.00398. eCollection 2020.
4
The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma.诱导化疗与放疗之间的时间间隔延长与鼻咽癌患者的预后不良有关。
Radiat Oncol. 2019 Jan 17;14(1):9. doi: 10.1186/s13014-019-1213-4.
5
Prognostic value of wait time in nasopharyngeal carcinoma treated with intensity modulated radiotherapy: a propensity matched analysis.调强放疗治疗鼻咽癌时等待时间的预后价值:一项倾向匹配分析
Oncotarget. 2016 Mar 22;7(12):14973-82. doi: 10.18632/oncotarget.7789.
6
Concurrent chemoradiotherapy for T3-4 and N0-1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia.T3-4期和N0-1期鼻咽癌同步放化疗:亚洲核合作论坛的亚洲多中心试验
J Radiat Res. 2016 Jan;57(1):44-9. doi: 10.1093/jrr/rrv046. Epub 2015 Aug 8.

本文引用的文献

1
Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.9388例头颈癌患者共病情况评估:一项来自丹麦头颈癌组(DAHANCA)数据库的全国队列研究
Radiother Oncol. 2014 Jan;110(1):91-7. doi: 10.1016/j.radonc.2013.11.009. Epub 2014 Jan 8.
2
The combined effect of individual and neighborhood socioeconomic status on nasopharyngeal cancer survival.个体和邻里社会经济地位对鼻咽癌生存的综合影响。
PLoS One. 2013 Sep 12;8(9):e73889. doi: 10.1371/journal.pone.0073889. eCollection 2013.
3
Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy.在同步化疗治疗的头颈癌中,放疗时间延长会增加局部失败风险。
Head Neck. 2014 Aug;36(8):1120-5. doi: 10.1002/hed.23419. Epub 2013 Nov 27.
4
Radiotherapy demand and activity in England 2006-2020.2006-2020 年英格兰的放射治疗需求和活动。
Clin Oncol (R Coll Radiol). 2013 Sep;25(9):522-30. doi: 10.1016/j.clon.2013.05.005. Epub 2013 Jun 12.
5
Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis.非洲放射治疗资源状况:国际原子能机构分析。
Lancet Oncol. 2013 Apr;14(4):e168-75. doi: 10.1016/S1470-2045(12)70532-6.
6
Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.种族、保险、社会经济地位和医院类型对局部区域性乳腺癌辅助系统治疗的指南一致性的影响。
J Clin Oncol. 2012 Jan 10;30(2):142-50. doi: 10.1200/JCO.2011.36.8399. Epub 2011 Dec 5.
7
Impact of comorbidity on therapeutic decision-making in head and neck cancer: audit from a comprehensive cancer center in India.合并症对头颈部癌症治疗决策的影响:来自印度综合癌症中心的审计。
Head Neck. 2012 Sep;34(9):1251-4. doi: 10.1002/hed.21897. Epub 2011 Nov 11.
8
Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan.台湾缺血性脑卒中病例对全民健康保险研究数据库的验证。
Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):236-42. doi: 10.1002/pds.2087. Epub 2010 Dec 29.
9
Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324.诱导化疗后局部晚期头颈部癌放疗时间与总生存的关系:TAX 324 的亚组分析。
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e813-8. doi: 10.1016/j.ijrobp.2010.12.005. Epub 2011 Feb 6.
10
The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials.同期放化疗在地方性高发人群局部晚期鼻咽癌治疗中的作用:III 期随机试验的荟萃分析。
BMC Cancer. 2010 Oct 15;10:558. doi: 10.1186/1471-2407-10-558.